HT
EVH icon

HAP Trading’s Evolent Health EVH Stock Holding History

HAP Trading’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,500
Closed -$86.4K – 770
2024
Q3 		$86.4K Buy
34,500
+17,000
+97% +$438K 0.01% 415
2024
Q2 		$151K Hold
17,500
– – 0.02% 322
2024
Q1 		$32.4K Hold
17,500
– – ﹤0.01% 476
2023
Q4 		$41.1K Hold
17,500
– – 0.01% 481
2023
Q3 		$71.8K Buy
+17,500
New +$486K 0.01% 446
2021
Q4 		– Sell
-163,300
Closed -$82K – 2617
2021
Q3 		$82K Buy
+163,300
New +$3.92M ﹤0.01% 1327

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

HAP Trading's EVH Position: Q3 2024 in Review

HAP Trading sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 12,783 shares — an estimated $329K sold.

HAP Trading first reported a position in EVH in Q3 2017 and held it in 3 quarters. The position peaked at $2.12M in Q3 2021. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • HAP Trading reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • HAP Trading sold 12,783 Evolent Health shares in Q3 2024, an estimated $329K.
  • HAP Trading first reported a position in Evolent Health in Q3 2017 and held it in 3 quarters.
  • HAP Trading's Evolent Health position peaked at $2.12M in Q3 2021.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on HAP Trading's 13F filing for Q3 2024, filed 12 Nov 2024.